Recombinant rabbit monoclonal antibodies as affinity captures for peptides

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201500044C
Awardee
Awarding agency
Obligated
$999,996

Award facts

Opportunity
  • N44CO5102475 Solicitation number
Contract value 100% obligated
$999,996.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition after exclusion of sources · 5 offers Alternative Sources
Pricing
Cost Plus Fixed Fee
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 · Other functions: recombinant rabbit monoclonal antibodies as affinity captures for peptides. $0
Original award $999,996

About this award

The National Cancer Institute awarded a definitive contract to Avantgen Inc. for recombinant rabbit monoclonal antibodies as affinity captures for peptides on September 22, 2015, with a ceiling value of $999,996 and an ultimate completion date of September 21, 2018.

The contract is priced on a cost-plus-fixed-fee basis with no set-aside applied. Place of performance is San Diego, CA 92121.

Quick answers

Who was awarded contract HHSN261201500044C?

HHSN261201500044C was awarded to Avantgen Inc. by National Cancer Institute (National Institutes of Health) on September 22, 2015.

How much is contract HHSN261201500044C worth?

The government has obligated $999,996 on HHSN261201500044C.

Was contract HHSN261201500044C competed?

The extent of competition for HHSN261201500044C was full and open competition after exclusion of sources. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award